Sector
PharmaceuticalsOpen
₹58Prev. Close
₹57.84Turnover(Lac.)
₹4.49Day's High
₹59.35Day's Low
₹57.252 Week's High
₹88.952 Week's Low
₹46.6Book Value
₹37.65Face Value
₹10Mkt Cap (₹ Cr.)
53.54P/E
52.29EPS
1.11Divi. Yield
05 Sep 2023
12:00 AM
BookCloser
5 Sep 2023
12:00 AM
AGM
Announcement Date: 05 Sep, 2023
21 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 9.22 | 9.22 | 9.22 | 0.41 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 24.46 | 24 | 17.4 | -0.01 |
Net Worth | 33.68 | 33.22 | 26.62 | 0.4 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 |
|---|---|---|
Revenue | 243.47 | 0 |
yoy growth (%) | 0 | |
Raw materials | -198.11 | 0 |
As % of sales | 81.36 | 0 |
Employee costs | -5.57 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 |
|---|---|---|
Profit before tax | 4.05 | -0.01 |
Depreciation | -1.8 | 0 |
Tax paid | -2.27 | 0 |
Working capital | 20.32 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | 0 | |
Op profit growth | -73,470.7 | |
EBIT growth | -60,673.29 | |
Net profit growth | -16,135.75 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Gaddam Venkata Ramana
Whole Time Director & CFO
Bhupathiraju S Raju
Non Executive Director
Kandula Murali Mohan
Independent Director
Dilip V Acharekar
Independent Director
K. Bhaskar Reddy
Company Secretary
Nirosha Ravikanti
Additional Director
Yerukalapudi Hari Priya
Company Sec. & Compli. Officer
Rameshkumar Bandari
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vineet Laboratories Ltd
Summary
Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of API Intermediates, Bulk Drugs & fine chemicals.The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size. Special provisions are made to carry out reactions at very low temperature (up to -100C). The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.The Company export the API intermediates, fine chemicals and custom synthesis molecules. The Company is interested in collaborating with exporters who want high quality products for export to other countries. In addition to the list of products enlisted in the website, the Company can manufacture as per customer requirements ,in case having any specific requirement.The Company constructed a warehouse with facilities for sampling both, dispensing booth, packing material room, rejected material room, intermediate room and a day storage for dispensed material 20 calibrated storage tanks from 10 KL to 40 KL available to store various solvents in dedicated tanks. All tanks are equipped with sprinklers and bund walls.The res
Read More
What is the Vineet Laboratories Ltd share price today?
The Vineet Laboratories Ltd shares price on N/A is Rs.₹58.39 today.
What is the Market Cap of Vineet Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vineet Laboratories Ltd is ₹53.83 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Vineet Laboratories Ltd?
The PE and PB ratios of Vineet Laboratories Ltd is 52.29 and 1.54 as of 22 Jul ‘24
What is the 52 Week High and Low of Vineet Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Vineet Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vineet Laboratories Ltd is ₹46.1 and ₹88.95 as of 22 Jul ‘24
What is the CAGR of Vineet Laboratories Ltd?
Vineet Laboratories Ltd's CAGR for 5 Years at 4.29%, 3 Years at -18.61%, 1 Year at 11.98%, 6 Month at -22.68%, 3 Month at 14.36% and 1 Month at -1.01%.
What is the shareholding pattern of Vineet Laboratories Ltd?
The shareholding pattern of Vineet Laboratories Ltd is as follows:
Promoters - 37.50 %
Institutions - 0.00 %
Public - 62.50 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
